Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

September 8, 2016September 8, 2016

Post-Surgery Chemo May Aid Malignant Pleural Mesothelioma Patients with Poor Prognosis

News

The timing of additional chemotherapy may influence the survival of certain patients with malignant pleural mesothelioma (MPM) who undergo radical surgery, according to a recent retrospective study published in Lung ... Read more

September 6, 2016September 6, 2016

Specific Agents in Some Mesothelioma Patients Show Promise as Future Therapeutic Strategy

News

Patients with malignant mesothelioma whose tumor cells are unable to synthesize the amino acid arginine show marked improvements in progression-free survival when treated with agents that deplete arginine supply, according ... Read more

September 1, 2016September 1, 2016

Asbestos Preparation Methods Influence Malignant Mesothelioma Risk, Study Finds

News

To assess the toxic potential of asbestos fibers, the most common cause of malignant mesothelioma, asbestos-containing materials are first broken into small fibers. In a recent study, researchers at the University ... Read more

August 23, 2016August 23, 2016

Malignant Pleural Mesothelioma Diagnosis Accurate with Thoracoscopy

News

Medical thoracoscopy, a minimally invasive procedure that uses a small camera to perform biopsies and treatments in the chest, has improved over the last three decades allowing for more accurate ... Read more

August 18, 2016August 18, 2016

Yondelis Combined with Chemotherapy May Be Promising Mesothelioma Therapy Approach

News

Yondelis (trabectedin), an anti-tumor drug approved for the treatment of advanced soft tissue sarcoma and ovarian cancer, has shown promising results in malignant pleural mesothelioma (MPM) cells, exerting strong anti-tumor ... Read more

August 11, 2016August 11, 2016

Peritoneal Mesothelioma Linked to Chronic Inflammation of Crohn’s Disease in Study

News

The vast majority of malignant mesothelioma (MM) cases are caused by asbestos exposure, but reports have suggested that chronic inflammation may also lead to development of this cancer. In a recent ... Read more

August 9, 2016August 9, 2016

New Mesothelioma Therapy Soon to Enter Clinical Trials in Japan

News

A new anti-CD26 monoclonal antibody, YS110, may be a promising therapeutic approach for patients with malignant mesothelioma (MM), according to researchers at the Graduate School of Medicine, Juntendo University, in ... Read more

June 23, 2016June 23, 2016

Blocking Synthesis of Estrogen Hormone Slows Tumor Growth in Mice with MPM, Study Reports

News

Blocking the synthesis of estradiol, an estrogen hormone, in mice with malignant pleural mesothelioma (MPM) reduced tumor growth, researchers report, suggesting that therapeutic approaches to lower estradiol levels may be of help to people. The ... Read more

May 24, 2016May 24, 2016

Malignant Mesothelioma May be Prevented, Fought with Help from Food Compounds

News

Micronutrients found in certain foods and beverages of plant origin have anti-inflammatory and anti-tumoral properties that may help prevent or fight malignant mesothelioma (MM), according to the study “The Potential ... Read more

May 16, 2016May 16, 2016

MicroRNA Seen to Limit Tumor Growth, Invasion in Early Malignant Pleural Mesothelioma Study

News

A microRNA, miR-591, inhibits malignant pleural mesothelioma (MPM) cell proliferation and invasion, according to the study “Overexpression of micro ribonucleic acid-591 inhibits cell proliferation and invasion of malignant pleural mesothelioma cells,” ... Read more